ClearPoint Neuro, Inc. Annual report pursuant to section 13 and 15(d)

Annual report pursuant to section 13 and 15(d)

Note 6 - Related Party Notes Payable (Tables)

Note 6 - Related Party Notes Payable (Tables)

12 Months Ended

Dec. 31, 2012

Related Party Notes Payable [Abstract]

Assumptions Used in Calculating Fair Value of Derivative Liability [Table Text Block]

		December 31,
		2012				2011
Dividend yield			0%				0%
Expected volatility			41.98%				46.58%
Risk free interest rate			0.31%				0.25%
Expected remaining term (years)			1.8				0.15
Common stock price			$1.60				$0.60

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

Derivative liability at January 1, 2010		$	1,227,500
Gain on change in fair value of derivative liability			(1,227,500	)
Derivative liability at December 31, 2010 and 2011			-
Loss on change in fair value of derivative liability			789
Derivative liability at December 31, 2012		$	789

Schedule of Related Party Transactions [Table Text Block]

		2012				2011

BSC Notes - principal		$	4,338,601			$	3,500,000
Summer 2011 Notes - principal			-				1,310,000
Total related party notes payable - principal			4,338,601				4,810,000
Summer 2011 Notes - unamortized discount			-				(432,706	)
Total related party notes payable - unamortized discount			-				(432,706	)
BSC Notes - net			4,338,601				3,500,000
Summer 2011 Notes - net			-				877,294
Total related party notes payable - net		$	4,338,601			$	4,377,294